Spligation enables programmable chimeric RNA generation in living cells

This study demonstrates that fusing CRISPR-Csm complexes with the RNA ligase RtcB enables programmable RNA excision and the creation of chimeric transcripts ("spligation") in living cells, offering a novel method for precise RNA manipulation independent of canonical splice sites.

The Gist

Imagine your cell is a bustling factory. Inside this factory, there are thousands of instruction manuals (RNA) being read by workers to build products (proteins). Sometimes, a manual has a typo, a missing page, or a dangerous instruction that needs to be fixed.

For a long time, scientists had two main ways to fix these manuals:

1. The "Scissors" approach: Cut the whole manual up and throw it away (destroying the message).
2. The "Glue" approach: Try to glue pages back together, but only if the pages were already cut in a very specific, natural way (like a pre-perforated edge).

This new paper introduces a revolutionary new tool called "Spligation." Think of it as a programmable "Cut-and-Paste" machine that works directly inside the living cell, allowing scientists to surgically remove bad sections of an instruction manual or even stitch two different manuals together to create a brand-new hybrid manual.

Here is how it works, broken down into simple steps:

1. The Precision Scissors (CRISPR-Csm)

The team used a specific type of molecular scissors called CRISPR-Csm. Unlike other scissors that might chop up the whole manual or leave messy edges, these scissors are incredibly precise.

• The Analogy: Imagine a librarian who can find a specific sentence in a book and cut out exactly 6 letters, or 12 letters, or even 300 letters, leaving the rest of the book perfectly intact.
• The Catch: Usually, when you cut a piece of paper out of a book, the book falls apart. In the cell, when these scissors cut the RNA, the cell usually tries to destroy the whole thing.

2. The Molecular Glue (RtcB)

To stop the book from falling apart, the scientists added a special "glue" called RtcB.

• The Analogy: Think of RtcB as a super-fast repair crew. As soon as the scissors cut out the bad part, the repair crew immediately glues the two clean edges back together.
• The Innovation: The scientists realized that if they taped the scissors and the glue crew together (fusing them into one machine), the repair happens much faster and more efficiently. It's like having a "Scissors-Glue" combo tool that cuts and fixes in one smooth motion.

3. The "Spligation" Magic (Stitching Two Manuals)

The most exciting part is what happens when you cut two different instruction manuals.

• The Analogy: Imagine you have a manual for "How to Build a Car" and another for "How to Build a Boat." If you cut a page out of the Car manual and a page out of the Boat manual, and then glue them together, you get a weird new manual: "How to Build a Boat-Car."
• The Result: The scientists showed they could take a piece of one RNA and stitch it onto a completely different RNA. They call this "Spligation" (a mix of Splicing and Ligation). This creates a "chimeric" (hybrid) RNA that didn't exist before.

Why is this a Big Deal?

Before this, if you wanted to fix a specific part of a gene in a human cell, you usually had to edit the DNA (the master blueprint) in the nucleus, which is slow, risky, and permanent. Or, you had to rely on the cell's natural "glue" which only works at specific, pre-existing spots.

Spligation changes the game because:

• It's Editable: You can program it to cut anywhere you want, not just where nature allows.
• It's Temporary: It edits the RNA (the working copy), not the DNA (the master copy). This means the changes are temporary and safer, like editing a draft rather than the final printed book.
• It's Versatile: You can delete bad sections (like removing a "Stop" sign that stops protein production too early) or add new sections (like attaching a glowing tag to a protein so we can see it).

The Bottom Line

The scientists have built a molecular "Find, Cut, and Paste" tool that works inside living human cells. It allows them to rewrite the cell's instruction manuals with high precision, opening up new possibilities for treating diseases caused by genetic errors without needing to permanently alter the human genome. It's like giving the cell a pair of smart scissors and a super-glue, allowing us to rewrite the story of life, one sentence at a time.

Technical Summary

1. Problem Statement

Current RNA-targeting technologies face significant limitations in precise transcript manipulation:

• Cas13 (Type VI): While capable of RNA cleavage, it often triggers non-specific, widespread degradation of cellular RNAs ("collateral cleavage") and cannot easily create defined deletions or insertions.
• Cas13 (catalytically inactive): Can induce exon skipping or trans-splicing but is restricted to naturally occurring splice sites.
• Cas7-11 (Type III-E): Shows low cleavage efficiency and poor specificity in human cells.
• General Gap: There is a lack of tools capable of inducing precise, programmable deletions, insertions, or the fusion of two distinct RNA molecules (chimeric RNA generation) in living cells without relying on the endogenous spliceosome or genome editing.

2. Methodology

The authors leveraged the Type III-A CRISPR-Csm complex (from Streptococcus thermophilus) and the RNA ligase RtcB to develop a "cut-and-paste" RNA editing system.

• Core Mechanism:
  • Cleavage: The Csm complex, guided by a crRNA, cleaves target RNA at specific sites. Uniquely, Csm cleavage leaves 2',3'-cyclic phosphate (cP) and 5'-hydroxyl (5'-OH) termini.
  • Ligation: The enzyme RtcB specifically recognizes and ligates RNA fragments with these exact end chemistries (2',3'-cP and 5'-OH).
• Experimental Design:
  • Reporter Systems: The team utilized dual-fluorescence reporters (e.g., mCherry-stop-eGFP) to monitor both RNA degradation (loss of mCherry) and successful re-ligation (gain of eGFP).
  • Proximity Enhancement: To improve ligation efficiency, they created fusion constructs linking RtcB to the Csm3 subunit of the Csm complex. They tested various orthologs (human, archaeal, and bacterial E. coli RtcB) and linker configurations.
  • Trans-Ligation (Spligation): They designed a system where two separate transcripts (split halves of eGFP) are cleaved by Csm and subsequently ligated in trans to reconstitute a functional protein.
  • Donor Optimization: To facilitate trans-ligation, they engineered donor transcripts with alternative 5'-hydroxyl generation methods, including hammerhead ribozymes and Cas6-mediated cleavage (using the Cas6 encoded within the Csm plasmid), bypassing the need for a second Csm cut on the donor.
  • Endogenous Application: They applied the optimized system to endogenous human mRNAs (e.g., XIST, GAPDH) to fuse a donor template (encoding sfGFP) to the 3' end of the target transcript.

3. Key Contributions

• Discovery of "Spligation": The authors coined the term spligation to describe the process of Csm-mediated cleavage followed by RtcB-mediated ligation, resulting in chimeric RNA generation. This distinguishes the process from spliceosome-dependent trans-splicing.
• Csm-RtcB Fusion Optimization: They demonstrated that fusing bacterial (E. coli) RtcB to the Csm3 subunit significantly enhances ligation efficiency compared to human RtcB or trans-expression of RtcB, likely due to the bacterial enzyme's multi-turnover activity and lack of cofactor dependence.
• Programmable Micro- and Macro-Excisions: The system can remove short sequences (6–24 nt, maintaining reading frame) or large stretches (~300 nt) from a single transcript.
• Splice-Site Independence: Unlike traditional trans-splicing, spligation does not require canonical splice sites, allowing modifications at virtually any position in an endogenous transcript.

4. Key Results

• Re-ligation of Csm Cleavage Products: In human cells, a small fraction (~12%) of Csm-cleaved transcripts were re-ligated rather than degraded. These re-ligated products showed precise deletions in increments of 6 nucleotides, matching the Csm cleavage pattern.
• Enhanced Efficiency via Fusion:
  • Fusion of E. coli RtcB to Csm3 increased the efficiency of premature stop codon removal (restoring eGFP) by ~30% compared to Csm alone.
  • Co-localization of the nuclease and ligase was critical; trans-expression of RtcB failed to improve efficiency.
• Trans-Ligation (Spligation) Success:
  • Using a bipartite eGFP reporter, the team achieved >40% eGFP-positive cells when using optimized donor transcripts (Donor-v2/v3) containing WPRE elements and specific 5'-hydroxyl generation mechanisms (ribozymes or Cas6).
  • Sequencing confirmed the presence of chimeric RNA junctions at the expected Csm cleavage sites.
• Endogenous Modification: The system successfully generated recombinant mRNA in HEK293T cells by fusing a donor sfGFP sequence to endogenous transcripts (e.g., XIST), creating chimeric proteins without altering the genome or relying on natural introns.

5. Significance

• New RNA Editing Paradigm: Spligation provides a fully programmable method to edit RNA that is distinct from Cas13 (degradation) and Cas9 (DNA editing). It allows for precise "cut-and-paste" operations on RNA.
• Therapeutic Potential:
  • Nonsense Suppression: The ability to excise 6-nt multiples allows for the removal of premature stop codons while maintaining the reading frame.
  • Exon Skipping: The system can theoretically remove "poison exons" or toxic repeat expansions (e.g., in Huntington's disease) by cutting on either side of the unwanted sequence.
  • Chimeric Antigen Receptors (CARs): It offers a route to generate therapeutic chimeric proteins directly from endogenous transcripts.
• Research Applications:
  • Enables the study of RNA biology by tagging endogenous transcripts with fluorophores or aptamers without overexpression artifacts.
  • Allows for the correction of chromosomal translocations at the RNA level.
  • Provides a tool to edit RNA viruses within host cells.
• Mechanistic Insight: The study reveals that RtcB, previously known only for tRNA maturation and XBP1 splicing, can act on a broader range of endogenous RNA substrates when guided by Csm, suggesting a potential, previously uncharacterized RNA repair pathway in eukaryotes.

In summary, this work establishes spligation as a powerful, programmable tool for precise RNA manipulation in living cells, overcoming the limitations of current RNA-targeting technologies by combining site-specific cleavage with efficient, proximity-enhanced ligation.